Fundies.
English

Prelude Therapeutics Incorporated

EDGAR
PRLD Quarterly report (10-Q) · filed 2026-08-11

Annual consolidated revenue for 2025: about USD 12.14M, using the latest reported figures. The previous period, 2024, was about USD 7M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

5.7 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

-270.93%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -15454000 USD Source
  • Revenue: 5704000 USD Source

Operating cash flow

-15.6 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -37259000 USD Source
  • Operating Cash Flow: -21685000 USD Source

Free cash flow

-15.6 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -37259000 USD Source
  • Operating Cash Flow: -21685000 USD Source
  • Capital Expenditure: 0 USD Source
  • Capital Expenditure: 0 USD Source
Cash and cash equivalents
26.3 million USD Source
Exact value

26329000 USD

Long-term debt including current maturities
Not available
Shares outstanding
3.16 million shares Source
Exact value

3161653 shares

Reported share-count change

32.83% · 781 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 2380270 shares · 2018-12-31· Source
  • 3161653 shares · 2019-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

22.4 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Revenue: 6500000 USD · 2025-07-01 – 2025-09-30 Source
  • Revenue: 12140000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 6500000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 4580000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 5704000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-60.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -19725000 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: -99498000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -83041000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -10385000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -13921000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-33.3 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -79421000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -60306000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -56302000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -79421000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -21685000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -37259000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -21685000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

0 USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Capital expenditure: 67000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 67000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 67000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 67000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-33.3 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -79421000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -60306000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -56302000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -79421000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -21685000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -37259000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -21685000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 67000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 67000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 67000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 67000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-11.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2025-12-31
  • Operating income: 8 of 11 periods available· newest 2025-12-31
  • Net income: 8 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 8 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 8 of 11 periods available· newest 2025-12-31
  • Total assets: 2 of 11 periods available· newest 2025-12-31
  • Total liabilities: 2 of 11 periods available· newest 2025-12-31
  • Current assets: 2 of 11 periods available· newest 2025-12-31
  • Current liabilities: 2 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 2 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +73.4%

    Prior period

    USD 7 million

    –

    Current period

    USD 12.14 million

    –

    Exact inputs and evidence

    12140000 − 7000000 = 5140000 USD

    7000000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    12140000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 27.68 million

    Prior period

    −USD 127.17 million

    –

    Current period

    −USD 99.5 million

    –

    Exact inputs and evidence

    -99498000 − -127173000 = 27675000 USD

    -127173000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -99498000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 46.59 million

    Prior period

    −USD 102.89 million

    –

    Current period

    −USD 56.3 million

    –

    Exact inputs and evidence

    -56302000 − -102888000 = 46586000 USD

    -102888000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -56302000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -91.2%

    Prior period

    USD 764,000

    –

    Current period

    USD 67,000

    –

    Exact inputs and evidence

    67000 − 764000 = -697000 USD

    764000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    67000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 12.14 million 100% of revenue
  • Operating costs Derived USD 116.71 million 961% of revenue
  • Operating income −USD 104.57 million −861% of revenue
  • Tax, interest and other Derived −USD 5.07 million −42% of revenue
  • Net income −USD 99.5 million −820% of revenue

Cash

  • Operating cash flow −USD 56.3 million −464% of revenue
  • Capital expenditure USD 67,000 0.6% of revenue
  • Free cash flow Derived −USD 56.37 million −464% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2024 Operating loss: operating costs were 2,096% of revenue.
  • 2025 Operating loss: operating costs were 961% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2024 2024-01-01 – 2024-12-317000000 146714000 Derived -139714000 -12541000 Derived -127173000 -103652000 Derived
Source
2025 2025-01-01 – 2025-12-3112140000 116706000 Derived -104566000 -5068000 Derived -99498000 -56369000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 12.1M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.13.1M9.8M6.6M3.3M0.020242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2024Revenue7000000
2025Revenue12140000

Revenue growth

Change in revenue from the same financial period one year earlier.

73.4% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.79%59%40%20%0%20242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2024Year over yearNo prior comparable period
2025Year over year73.4%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -861.3% 2025
Net margin -819.6% 2025
Free cash flow margin -464.3% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.160%-419%-998%-1,577%-2,156%20242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2024Operating margin-1,995.9%
2025Operating margin-861.3%
2024Net margin-1,816.8%
2025Net margin-819.6%
2024Free cash flow margin-1,480.7%
2025Free cash flow margin-464.3%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -56.3M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8.2M-21.6M-51.4M-81.3M-111.1M20242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2024Operating cash flow-102888000
2025Operating cash flow-56302000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -56.4M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8.3M-21.8M-51.8M-81.9M-111.9M20242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2024Free cash flow-103652000
2025Free cash flow-56369000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

51.4% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.56%42%28%14%0%20242025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2024Liabilities / assets25.1%
2025Liabilities / assets51.4%

Current assets to current liabilities

Current assets divided by current liabilities.

1.99× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5.72×4.29×2.86×1.43×0.00×20242025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2024Current assets / current liabilities5.3×
2025Current assets / current liabilities1.99×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2018 2018-01-01 – 2018-12-31
−USD 14.68 million
Exact value

Exact value: -14680000 USD

2018-01-01 – 2018-12-31: -14680000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 12.95 million
Exact value

Exact value: -12954000 USD

2018-01-01 – 2018-12-31: -12954000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 529,000
Exact value

Exact value: 529000 USD

2018-01-01 – 2018-12-31: 529000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 13.48 million
Calculation and evidence

-12954000 − 529000 USD

Exact free cash flow: -13483000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 27.57 million
Exact value

Exact value: -27570000 USD

2019-01-01 – 2019-12-31: -27570000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 25.67 million
Exact value

Exact value: -25665000 USD

2019-01-01 – 2019-12-31: -25665000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 780,000
Exact value

Exact value: 780000 USD

2019-01-01 – 2019-12-31: 780000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 26.45 million
Calculation and evidence

-25665000 − 780000 USD

Exact free cash flow: -26445000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 56.93 million
Exact value

Exact value: -56929000 USD

2020-01-01 – 2020-12-31: -56929000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 46.18 million
Exact value

Exact value: -46177000 USD

2020-01-01 – 2020-12-31: -46177000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 621,000
Exact value

Exact value: 621000 USD

2020-01-01 – 2020-12-31: 621000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 46.8 million
Calculation and evidence

-46177000 − 621000 USD

Exact free cash flow: -46798000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 111.69 million
Exact value

Exact value: -111694000 USD

2021-01-01 – 2021-12-31: -111694000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 83.53 million
Exact value

Exact value: -83531000 USD

2021-01-01 – 2021-12-31: -83531000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.32 million
Exact value

Exact value: 2323000 USD

2021-01-01 – 2021-12-31: 2323000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 85.85 million
Calculation and evidence

-83531000 − 2323000 USD

Exact free cash flow: -85854000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 115.44 million
Exact value

Exact value: -115438000 USD

2022-01-01 – 2022-12-31: -115438000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 83.73 million
Exact value

Exact value: -83729000 USD

2022-01-01 – 2022-12-31: -83729000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.02 million
Exact value

Exact value: 3019000 USD

2022-01-01 – 2022-12-31: 3019000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 86.75 million
Calculation and evidence

-83729000 − 3019000 USD

Exact free cash flow: -86748000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 121.83 million
Exact value

Exact value: -121832000 USD

2023-01-01 – 2023-12-31: -121832000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 107.06 million
Exact value

Exact value: -107063000 USD

2023-01-01 – 2023-12-31: -107063000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.51 million
Exact value

Exact value: 3513000 USD

2023-01-01 – 2023-12-31: 3513000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 110.58 million
Calculation and evidence

-107063000 − 3513000 USD

Exact free cash flow: -110576000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 127.17 million
Exact value

Exact value: -127173000 USD

2024-01-01 – 2024-12-31: -127173000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 102.89 million
Exact value

Exact value: -102888000 USD

2024-01-01 – 2024-12-31: -102888000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 764,000
Exact value

Exact value: 764000 USD

2024-01-01 – 2024-12-31: 764000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 103.65 million
Calculation and evidence

-102888000 − 764000 USD

Exact free cash flow: -103652000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 99.5 million
Exact value

Exact value: -99498000 USD

2025-01-01 – 2025-12-31: -99498000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 56.3 million
Exact value

Exact value: -56302000 USD

2025-01-01 – 2025-12-31: -56302000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 67,000
Exact value

Exact value: 67000 USD

2025-01-01 – 2025-12-31: 67000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 56.37 million
Calculation and evidence

-56302000 − 67000 USD

Exact free cash flow: -56369000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

37 filings · 1,372 latest values · 1,372 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001678660, 1678660, PRLD, edgar:1678660

Also known as PRELUDE THERAPEUTICS INC, PRELUDE THERAPEUTICS INCORPORATED, Prelude Therapeutics Inc, Prelude Therapeutics Inc., Prelude Therapeutics Incorporated